Evidence map›Paper›PMID 25840750›Full record

ArticleDrug and alcohol dependence2015

Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.

Andy C Dean, Milky Kohno, Angelica M Morales, Dara G Ghahremani, Edythe D London

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Denial and Diagnosis of Methamphetamine Dependence Severity.Substance abuse : research and treatment · 2022
    Article
  8. Article
  9. Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.The Journal of pharmacology and experimental therapeutics · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Behavioral preference for viewing drugPsychological medicine · 2020
    Article
  15. Article
  16. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  17. Article
  18. Article
  19. Neural underpinnings of maladaptive decision-making in addictions.Pharmacology, biochemistry, and behavior · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andy C DeanDepartment of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA 90024, USA; Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA 90024, USA. Electronic address: acdean@mednet.ucla.edu.
Milky KohnoDepartment of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA 90024, USA.
Angelica M MoralesDepartment of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA 90024, USA.
Dara G GhahremaniDepartment of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA 90024, USA.
Edythe D LondonDepartment of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA 90024, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA 90024 USA; Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA 90024, USA.
University of California, Los Angeles · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
NEUROCHEMISTRY OF MODAFINIL-MA INTERACTION IN RAT BRAINP20DA022539 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LONDON, EDYTHE DANICK · 2006 to 2009
$2.9M
Neural Systems, Inhibitory Control, and Methamphetamine DependenceR01DA020726 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LONDON, EDYTHE DANICK · 2005 to 2008
$2.0M
Early Methamphetamine Abstinence: fMRI and CognitionR01DA015179 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LONDON, EDYTHE D · 2003 to 2005
$1.4M
Neurobehavioral Predictors of Cognitive Decline in Methamphetamine DependenceK23DA027734 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEAN, ANDREW CLARK · 2010 to 2014
$842k
CYP2D6, brain structure, and cognitive function in methamphetamine dependenceR21DA034928 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEAN, ANDREW CLARK · 2013 to 2014
$424k
Modulators of maladaptive decision-making in methamphetamine dependenceF31DA033120 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOHNO, MILKY · 2012 to 2013
$50k
ASSOCIATION BETWEEN ILLICIT DRUG USE AND BEHAVIORAL REPERTOIRE IN ADOLESCENTSZ01DA000331 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI ANTHONY, J · 1994 to 1995
–
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NCRR NIH HHS M01 RR000865NCRR NIH HHS M01 RR00865NIDA NIH HHS DA 020726NIDA NIH HHS DA 022539NIDA NIH HHS F31 DA0331-17NIDA NIH HHS F31 DA033120NIDA NIH HHS F31 DA033120-02NIDA NIH HHS K23 DA027734NIDA NIH HHS P20 DA022539NIDA NIH HHS R01 DA015179NIDA NIH HHS R01 DA020726NIDA NIH HHS R21 DA034928NIDA NIH HHS T32 DA024635
6 · The paper itself

Abstract

backgroundDespite harmful consequences of drug addiction, it is common for individuals with substance use disorders to deny having problems with drugs. Emerging evidence suggests that some drug users lack insight into their behavior due to neurocognitive dysfunction, but little research has examined potential neurocognitive contributions to denial.

methodsThis study explored the relationship between denial, cognitive performance and functional connectivity in brain. The participants were 58 non-treatment-seeking, methamphetamine-dependent participants who completed the URICA precontemplation scale, a self-report measure of denial of drug problems warranting change, as well as a cognitive test battery. A subset of participants (N = 21) had functional MRI scans assessing resting-state functional connectivity. Given literature indicating roles of the rostral anterior cingulate (rACC), anterior insula and precuneus in self-awareness, relationships between denial and resting-state connectivity were tested using seeds placed in these regions.

resultsThe results revealed a negative relationship between denial and an overall cognitive battery score (p = 0.001), the effect being driven particularly by performance on tests of memory and executive function. Denial was negatively associated with strength of connectivity between the rACC and regions of the frontal lobe (precentral gyri, left ventromedial prefrontal cortex, left orbitofrontal cortex), limbic system (left amygdala, left hippocampus and left parahippocampal gyrus), occipital lobes and cerebellum; and between the precuneus and the midbrain and cerebellum. Anterior insula connectivity was unrelated to denial.

conclusionsThese findings suggest that denial by methamphetamine users is linked with a cognitive and neural phenotype that may impede the development of insight into their behavior.

Indexed as

CognitionDenial, PsychologicalAdolescentAdultAmphetamine-Related DisordersBrainBrain MappingCentral Nervous System StimulantsFemaleFrontal LobeGyrus CinguliHumansMagnetic Resonance ImagingMaleMethamphetamineMiddle AgedCentral Nervous System StimulantsMethamphetamineAwarenessCognitionConnectivityDenialInsightSubstance abuse

Identifiers

PMID25840750
PMCPMC4447566
OpenAlexW2067807232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.